We use cookies for a better user experience. Read our Privacy Policy

I Agree

Point-of-Care Diagnostics Market

Point-of-Care Diagnostics Market (Platform: Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, and Others; Application and End-user) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Point-of-Care Diagnostics Market Outlook 2028

  • The global point-of-care diagnostics market was valued at US$ 34.1 Bn in 2020
  • It is estimated to expand at a CAGR of 4.7% from 2021 to 2028
  • The global point-of-care diagnostics market is expected to reach the value of US$ 66 Bn by the end of 2028

Analysts’ Viewpoint on Point-of-Care Diagnostics Market Scenario

North America is expected to offer lucrative opportunities to the point-of-care diagnostics market players. This is due to rising geriatric population and increasing prevalence of cancer, diabetes, and cardiovascular diseases. The surge in demand for home healthcare services across the globe is creating potential growth prospects for players in the point-of-care diagnostics market. Moreover, rise in prevalence of infectious diseases such as HIV/AIDS and malaria is expected to drive the demand for point-of-care diagnostics. Favorable reimbursement policies are responsible for the rapid expansion of the global point-of-care diagnostics market during the forecast period.

Innovative Strategies Adopted by Market Players to Gain Competitive Benefits

R&D activities have a large part to play in strengthening the growth structure of the point-of-care diagnostics market. The players indulge in these activities for adding new technologies to the systems. Furthermore, the activities also assist in increasing the revenues of the players in the point-of-care diagnostics market. Strategic collaborations have a major role in expanding the landscape of the point-of-care diagnostics market. Mergers, acquisitions, joint ventures, and partnerships are important in boosting the influence of the players in various regional pockets. These collaborations also aid in increasing the production capacities of the players in the point-of-care diagnostics market, eventually accelerating the growth prospects.

Request a sample to get extensive insights into the Point-of-Care Diagnostics Market

Increase in Preference for Biosensor Integration to Drive Global Market

A blend of biosensors in point-of-care diagnostics devices help improve patient care via real-time and remote health monitoring. Furthermore, label-based techniques are time consuming and cause many complexities. These factors are accelerating the use of point-of-care diagnostics devices, ultimately contributing to the growth structure of the point-of-care diagnostics market. Point-of-care diagnostics helps healthcare practitioners to efficiently and accurately attain real-time and high-quality results in a short span. These diagnostics help physicians, clinicians, and other healthcare professionals to make quick decisions related to the line of treatment to be given to a patient.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Lucrative Growth Opportunities for North America Market Players

The North America point-of-care diagnostics market is expected to account for the largest share of the global market. This can be attributed to the availability of advanced healthcare infrastructure and technological growth.

The point-of-care diagnostics market in Asia Pacific is projected to expand at a rapid pace during the forecast period. The region is expected to gain market share due to rising population, government initiatives to provide better health care facilities, growing number of patients affected by various viral diseases. Rise in disposable income of people also contributes to the expansion of the market in Asia Pacific.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Point-of-Care Diagnostics Market

Governments Extend Support to Improve Healthcare Infrastructure

Due to the COVID-19 pandemic, an increase in the strain on the healthcare sector was witnessed due to increased hospitalization and complications among many individuals. These aspects are encouraging many government bodies to improve their healthcare infrastructure. This, in turn, is propelling the growth of the point-of-care diagnostics market. The advantages associated with point-of-care diagnostics devices are estimated to have a positive impact on the growth trajectory of the point-of-care diagnostics market during the forecast period. Manufacturers operating in the global point-of-care diagnostics market are focusing on innovations in services to boost the global market. Companies in the global point-of-care diagnostics market are accelerating product development and unlocking revenue opportunities to obtain competitive benefits. Market stakeholders are extending their services arms to gain competitive edge in healthcare sector.

Impact of Coronavirus on Global Point-of-Care Diagnostics Market

The COVID-19 pandemic has changed the growth equation of many industries and sectors in different ways. The growth projections of the point-of-care diagnostics market have also been affected due to the pandemic. Numerous countries are ramping up COVID-19 testing measures for early detection and death prevention due to the infection. The novel coronavirus, if detected at a later stage, may spread at a rapid rate and also infect the lungs, which can prove to be dangerous, or even fatal in some cases. Hence, government bodies are upgrading COVID-19 testing measures. These factors assure accelerated growth of the point-of-care diagnostics market. The benefits attached to the use of point-of-care diagnostics as compared to other techniques are predicted to strengthen the growth prospects of the global market. Other aspects such as precision, accuracy, and enhanced sensitivity assist in increasing the growth rate of the point-of-care diagnostics market.

Point-of-Care Diagnostics Market: Overview

  • According to Transparency Market Research’s latest report on the global point-of-care diagnostics market for the historical period 2017–2019 and forecast period 2021–2028, increase in incidence of diabetes, cancer, and other chronic diseases, and technological advancements in the field of point-of-care that has resulted in new and innovative products are projected to drive the global point-of-care diagnostics market during the forecast period

Rise in Prevalence of Chronic, Infectious, and Lifestyle Diseases: Key Driver

  • The number of patients inflicted with infectious diseases and other lifestyle diseases is increasing. However, early screening at the onset stage prevents the last stage complications and health care costs for patients.
  • According to the IDF Diabetes Atlas Tenth edition 2021, around 537 million adults (20 years to 79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.
  • Using data from 2015 to 2018, around 93.9 million, or 38.1%, of the U.S. adults had total cholesterol of 200 mg/dL or higher, according to the American Heart Association, Inc.

Technological Innovations to Boost Market Growth

  • Technological innovations that provide early, safe, and accurate results for diagnosis are projected to boost the growth of the global point-of-care diagnostics market. Advanced technology helps in continually updating the market by bringing on better products.
  • Introduction of the fifth generation HIV test for diagnosis helps patients with early detection of HIV infection by diagnosing HIV antigen. The 5th generation HIV test provides more information than ever before about a person's HIV status. Moreover, this test can now detect and identify both HIV-1 and HIV-2 antibodies and the p24 antigen individually in one blood sample, thereby specifically indicating which marker is positive. The 4th generation test reports on all three markers together.
  • In response to the ongoing two-year-long COVID-19 outbreak, the World Health Organization (WHO) has supported bedside diagnostics as a major research priority. In comparison to the gold standard lab-based PCR test, the goal is to enhance turnaround time and ease of use. Rapid antigen tests, alternative DNA amplification technologies, and innovative sensors in close proximity to patients have all been used.
  • With built-in sensors, high-resolution cameras, high-speed wireless connectivity, and the capacity to use numerous applications and apps, smartphones operate as minicomputers for sensitive and particular data quantification. Hence, these can be used in mobile POCT as standalone sensors and detectors.

Lack of Quantification in Results of Point-of-Care Diagnostics to Hamper Global Market

  • Rapid medical diagnostic kits provide for only qualitative results for the tests performed. These results are easily observable. For confirmation of the test results, other diagnostic methods have to be deployed, which increases the health care costs incurred by patients.
  • Rapid diagnostic test kit for malaria was used to check for malarial antigens at onset stage. The results were indicative of the presence of malarial antigens; however, the amount or quantity was not observed.

Point-of-Care Diagnostics Market: Competition Landscape

  • This report profiles major players in the global point-of-care diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global point-of-care diagnostics market is consolidated, with the presence of small number of major global players
  • Leading players operating in the global point-of-care diagnostics market are
    • Johnson & Johnson Services, Inc.
    • bioMérieux SA
    • F. Hoffmann-La Roche Ltd.
    • Nova Biomedical
    • Siemens AG
    • Bio Rad Laboratories, Inc.
    • BD
    • Abbott
    • Danaher Corporation
    • Cardinal Health Inc.
    • Thermo Fisher Scientific, Inc., among others

Point-of-Care Diagnostics Market: Key Developments

  • Key players in the global point-of-care diagnostics market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global point-of-care diagnostics market. A few expansion strategies adopted by players operating in the global point-of-care diagnostics market are:
    • In February 2022, Mylab Discovery Solutions announced the approval and launch of CoviSwift for testing for COVID-19. CoviSwift is the first point-of-care testing solution that can be used in small labs, in-hospital labs, and airports. CoviSwift is driven by RT-PCR gold standard technology as against the CoviSelf rapid antigen home testing kit. The test is expected to be available in the market by early February.
    • In April 2021, CA Healthcare Acquisition Corp. announced a definitive merger agreement with LumiraDx Limited. The combination reflects a value of US$ 5.0 Bn for Lumira’s existing equity. Since its formation, LumiraDx has raised US$ 700 Mn in equity capital including investments by Morningside Ventures, U.S. Boston Capital Corporation, the Bill & Melinda Gates Foundation, Petrichor Healthcare Capital Management, and other global strategic partners.
  • The report on the global point-of-care diagnostics market discusses individual strategies, followed by company profiles of manufacturers of point-of-care diagnostic devices/kits. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global point-of-care diagnostics market.

Point-of-Care Diagnostics Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 34.1 Bn

Market Forecast Value in 2028

US$ 66.0 Bn

Growth Rate (CAGR)

4.7%

Forecast Period

2021–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market player – Competition matrix (by tier and size of companies)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Platform
    • Lateral Flow Assays
    • Dipsticks
    • Microfluidics
    • Molecular Diagnostics
    • Immunoassays
    • Others
  • Application
    • Glucose Monitoring Products
    • Cardiometabolic Monitoring Products
    • Infectious Disease Testing Products
    • Pregnancy & Fertility Testing Products
    • Urinalysis Testing Products
    • Cholesterol Testing Products
    • Hematology Testing Products
    • Drugs-of-abuse Testing Products
    • Others
  • End-user
    • Hospitals
    • Diagnostic Laboratories
    • Clinics/Physician Offices
    • Home Care
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Johnson & Johnson Services, Inc.
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd.
  • Nova Biomedical
  • Siemens AG
  • Bio-Rad Laboratories, Inc.
  • BD
  • Abbott
  • Danaher Corporation
  • Cardinal Health, Inc.
  • Thermo Fisher Scientific, Inc.
  • Other Prominent Players

Customization Scope

Available upon request

Pricing

Available upon request

Point-of-Care Diagnostics Market – Segmentation

Platform
  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays
  • Others
Application
  • Glucose Monitoring Products
  • Cardiometabolic Monitoring Products
  • Infectious Disease Testing Products
  • Pregnancy & Fertility Testing Products
  • Urinalysis Testing Products
  • Cholesterol Testing Products
  • Hematology Testing Products
  • Drugs-of-abuse Testing Products
  • Others
End-user
  • Hospitals
  • Diagnostic Laboratories
  • Clinics / Physician Offices
  • Home Care
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Point-of-Care Diagnostics Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of point-of-care diagnostics market?

Point-of-care diagnostics market is expected to reach the value of US$ 66 Bn by the end of 2028

What is the anticipated CAGR of the point-of-care diagnostics market in the forecast period?

Point-of-care diagnostics market is estimated to expand at a CAGR of 4.7% from 2021 to 2028

What are the key driving factors for the growth of the point-of-care diagnostics market?

Point-of-care diagnostics market is driven by rise in prevalence of infectious diseases such as HIV/AIDS and malaria

Which is the rising prominent segment in the point-of-care diagnostics market?

The lateral flow assays segment accounted for the largest share of the global point-of-care diagnostics market

Who are the key players in the global point-of-care diagnostics market?

Key players in the global point-of-care diagnostics market include Johnson & Johnson Services, Inc., bioMérieux SA, F. Hoffmann-La Roche Ltd., Nova Biomedical, Siemens AG

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Point-of-Care Diagnostics Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Point-of-Care Diagnostics Market Analysis and Forecast, 2017–2028

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Disease Prevalence & Incidence Rate globally with key countries

    5.2. Technological Advancements

    5.3. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)

    5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Point-of-Care Diagnostics Market Analysis and Forecast, by Platform

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Platform, 2017–2028

        6.3.1. Lateral Flow Assays

        6.3.2. Dipsticks

        6.3.3. Microfluidics

        6.3.4. Molecular Diagnostics

        6.3.5. Immunoassays

        6.3.6. Others

    6.4. Market Attractiveness Analysis, by Platform

7. Global Point-of-Care Diagnostics Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2017–2028

        7.3.1. Glucose Monitoring Products

        7.3.2. Cardiometabolic Monitoring Products

        7.3.3. Infectious Disease Testing Products

        7.3.4. Pregnancy & Fertility Testing Products

        7.3.5. Urinalysis Testing Products

        7.3.6. Cholesterol Testing Products

        7.3.7. Hematology Testing Products

        7.3.8. Drugs-of-abuse Testing Products

        7.3.9. Others

    7.4. Market Attractiveness Analysis, by Application

8. Global Point-of-Care Diagnostics Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by End-user, 2017–2028

        8.3.1. Hospitals

        8.3.2. Diagnostic Laboratories

        8.3.3. Clinics/Physician Offices

        8.3.4. Home Care

        8.3.5. Others

    8.4. Market Attractiveness Analysis, by End-user

9. Global Point-of-Care Diagnostics Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Point-of-Care Diagnostics Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Platform, 2017–2028

        10.2.1. Lateral Flow Assays

        10.2.2. Dipsticks

        10.2.3. Microfluidics

        10.2.4. Molecular Diagnostics

        10.2.5. Immunoassays

        10.2.6. Others

    10.3. Market Value Forecast, by Application, 2017–2028

        10.3.1. Glucose Monitoring Products

        10.3.2. Cardiometabolic Monitoring Products

        10.3.3. Infectious Disease Testing Products

        10.3.4. Pregnancy & Fertility Testing Products

        10.3.5. Urinalysis Testing Products

        10.3.6. Cholesterol Testing Products

        10.3.7. Hematology Testing Products

        10.3.8. Drugs-of-abuse Testing Products

        10.3.9. Others

    10.4. Market Value Forecast, by End-user, 2017–2028

        10.4.1. Hospitals

        10.4.2. Diagnostic Laboratories

        10.4.3. Clinics/Physician Offices

        10.4.4. Home Care

        10.4.5. Others

    10.5. Market Value Forecast, by Country, 2017–2028

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Platform

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Point-of-Care Diagnostics Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Platform, 2017–2028

        11.2.1. Lateral Flow Assays

        11.2.2. Dipsticks

        11.2.3. Microfluidics

        11.2.4. Molecular Diagnostics

        11.2.5. Immunoassays

        11.2.6. Others

    11.3. Market Value Forecast, by Application, 2017–2028

        11.3.1. Glucose Monitoring Products

        11.3.2. Cardiometabolic Monitoring Products

        11.3.3. Infectious Disease Testing Products

        11.3.4. Pregnancy & Fertility Testing Products

        11.3.5. Urinalysis Testing Products

        11.3.6. Cholesterol Testing Products

        11.3.7. Hematology Testing Products

        11.3.8. Drugs-of-abuse Testing Products

        11.3.9. Others

    11.4. Market Value Forecast, by End-user, 2017–2028

        11.4.1. Hospitals

        11.4.2. Diagnostic Laboratories

        11.4.3. Clinics/Physician Offices

        11.4.4. Home Care

        11.4.5. Others

    11.5. Market Value Forecast, by Country/Sub-Region, 2017–2028

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Platform

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-Region

12. Asia Pacific Point-of-Care Diagnostics Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Platform, 2017–2028

        12.2.1. Lateral Flow Assays

        12.2.2. Dipsticks

        12.2.3. Microfluidics

        12.2.4. Molecular Diagnostics

        12.2.5. Immunoassays

        12.2.6. Others

    12.3. Market Value Forecast, by Application, 2017–2028

        12.3.1. Glucose Monitoring Products

        12.3.2. Cardiometabolic Monitoring Products

        12.3.3. Infectious Disease Testing Products

        12.3.4. Pregnancy & Fertility Testing Products

        12.3.5. Urinalysis Testing Products

        12.3.6. Cholesterol Testing Products

        12.3.7. Hematology Testing Products

        12.3.8. Drugs-of-abuse Testing Products

        12.3.9. Others

    12.4. Market Value Forecast, by End-user, 2017–2028

        12.4.1. Hospitals

        12.4.2. Diagnostic Laboratories

        12.4.3. Clinics/Physician Offices

        12.4.4. Home Care

        12.4.5. Others

    12.5. Market Value Forecast, by Country/Sub-Region, 2017–2028

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Platform

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-Region

13. Latin America Point-of-Care Diagnostics Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Platform, 2017–2028

        13.2.1. Lateral Flow Assays

        13.2.2. Dipsticks

        13.2.3. Microfluidics

        13.2.4. Molecular Diagnostics

        13.2.5. Immunoassays

        13.2.6. Others

    13.3. Market Value Forecast, by Application, 2017–2028

        13.3.1. Glucose Monitoring Products

        13.3.2. Cardiometabolic Monitoring Products

        13.3.3. Infectious Disease Testing Products

        13.3.4. Pregnancy & Fertility Testing Products

        13.3.5. Urinalysis Testing Products

        13.3.6. Cholesterol Testing Products

        13.3.7. Hematology Testing Products

        13.3.8. Drugs-of-abuse Testing Products

        13.3.9. Others

    13.4. Market Value Forecast, by End-user, 2017–2028

        13.4.1. Hospitals

        13.4.2. Diagnostic Laboratories

        13.4.3. Clinics/Physician Offices

        13.4.4. Home Care

        13.4.5. Others

    13.5. Market Value Forecast, by Country/Sub-Region, 2017–2028

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Platform

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-Region

14. Middle East & Africa Point-of-Care Diagnostics Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Platform, 2017–2028

        14.2.1. Lateral Flow Assays

        14.2.2. Dipsticks

        14.2.3. Microfluidics

        14.2.4. Molecular Diagnostics

        14.2.5. Immunoassays

        14.2.6. Others

    14.3. Market Value Forecast, by Application, 2017–2028

        14.3.1. Glucose Monitoring Products

        14.3.2. Cardiometabolic Monitoring Products

        14.3.3. Infectious Disease Testing Products

        14.3.4. Pregnancy & Fertility Testing Products

        14.3.5. Urinalysis Testing Products

        14.3.6. Cholesterol Testing Products

        14.3.7. Hematology Testing Products

        14.3.8. Drugs-of-abuse Testing Products

        14.3.9. Others

    14.4. Market Value Forecast, by End-user, 2017–2028

        14.4.1. Hospitals

        14.4.2. Diagnostic Laboratories

        14.4.3. Clinics/Physician Offices

        14.4.4. Home Care

        14.4.5. Others

    14.5. Market Value Forecast, by Country/Sub-Region, 2017–2028

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Platform

        14.6.2. By Application

        14.6.3. By End-user

        14.6.4. By Country/Sub-Region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company, 2020

    15.3. Company Profiles

        15.3.1. F. Hoffmann-La Roche Ltd.

            15.3.1.1. Overview (HQ, Employee Strength, Business Segments)

            15.3.1.2. Financials

            15.3.1.3. Recent Developments & Strategy

            15.3.1.4. SWOT Analysis

        15.3.2. bioMérieux SA

            15.3.2.1. Overview (HQ, Employee Strength, Business Segments)

            15.3.2.2. Financials

            15.3.2.3. Recent Developments & Strategy

            15.3.2.4. SWOT Analysis

        15.3.3. Johnson & Johnson Services, Inc.

            15.3.3.1. Overview (HQ, Employee Strength, Business Segments)

            15.3.3.2. Financials

            15.3.3.3. Recent Developments & Strategy

            15.3.3.4. SWOT Analysis

        15.3.4. Cardinal Health, Inc.

            15.3.4.1. Overview (HQ, Employee Strength, Business Segments)

            15.3.4.2. Financials

            15.3.4.3. Recent Developments & Strategy

            15.3.4.4. SWOT Analysis

        15.3.5. Siemens AG

            15.3.5.1. Overview (HQ, Employee Strength, Business Segments)

            15.3.5.2. Financials

            15.3.5.3. Recent Developments & Strategy

            15.3.5.4. SWOT Analysis

        15.3.6. Bio Rad Laboratories, Inc.

            15.3.6.1. Overview (HQ, Employee Strength, Business Segments)

            15.3.6.2. Financials

            15.3.6.3. Recent Developments & Strategy

            15.3.6.4. SWOT Analysis

        15.3.7. BD

            15.3.7.1. Overview (HQ, Employee Strength, Business Segments)

            15.3.7.2. Financials

            15.3.7.3. Recent Developments & Strategy

            15.3.7.4. SWOT Analysis

        15.3.8. Abbott

            15.3.8.1. Overview (HQ, Employee Strength, Business Segments)

            15.3.8.2. Financials

            15.3.8.3. Recent Developments & Strategy

            15.3.8.4. SWOT Analysis

        15.3.9. Danaher Corporation

            15.3.9.1. Overview (HQ, Employee Strength, Business Segments)

            15.3.9.2. Financials

            15.3.9.3. Recent Developments & Strategy

            15.3.9.4. SWOT Analysis

        15.3.10. Thermo Fisher Scientific, Inc.

            15.3.10.1. Overview (HQ, Employee Strength, Business Segments)

            15.3.10.2. Financials

            15.3.10.3. Recent Developments & Strategy

            15.3.10.4. SWOT Analysis

List of Tables

Table 01: Global Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017‒2028

Table 02: Global Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2028

Table 03: Global Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2028

Table 04: Global Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2028

Table 05: North America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2028

Table 06: North America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017‒2028

Table 07: North America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2028

Table 08: North America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2028

Table 09: Europe Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2028

Table 10: Europe Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017‒2028

Table 11: Europe Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2028

Table 12: Europe Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2028

Table 13: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 14: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017‒2028

Table 15: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2028

Table 16: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2028

Table 17: Latin America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2028

Table 18: Latin America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017‒2028

Table 19: Latin America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2028

Table 20: Latin America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2028

Table 21: Middle East & Africa Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2028

Table 22: Middle East & Africa Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017‒2028

Table 23: Middle East & Africa Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2028

Table 24: Middle East & Africa Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2028

List of Figures

Figure 01: Global Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017–2028

Figure 02: Point-of-Care Diagnostics Market Value Share, by Platform, 2020

Figure 03: Point-of-Care Diagnostics Market Value Share, by Application, 2020

Figure 04: Point-of-Care Diagnostics Market Value Share, by End-user, 2020

Figure 05: Global Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028

Figure 06: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021–2028

Figure 07: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Lateral Flow Assays, 2017‒2028

Figure 08: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Dipsticks, 2017‒2028

Figure 09: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Microfluidics, 2017‒2028

Figure 10: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Molecular Diagnostics, 2017‒2028

Figure 11: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Immunoassays, 2017‒2028

Figure 12: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Others, 2017‒2028

Figure 13: Global Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028

Figure 14: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021–2028

Figure 15: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Glucose Monitoring Products, 2017–2028

Figure 16: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Cardiometabolic Monitoring Products, 2017–2028

Figure 17: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Infectious Disease Testing Products, 2017–2028

Figure 18: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Pregnancy & Fertility Testing Products, 2017–2028

Figure 19: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Urinalysis Testing Products, 2017–2028

Figure 20: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Cholesterol Testing Products, 2017–2028

Figure 21: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Hematology Testing Products, 2017–2028

Figure 22: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Drugs-of-abuse Testing Products, 2017–2028

Figure 23: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Others, 2017–2028

Figure 24: Global Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028

Figure 25: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021–2028

Figure 26: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Hospitals, 2017–2028

Figure 27: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Diagnostic Laboratories, 2017–2028

Figure 28: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Clinics/Physician Offices, 2017–2028

Figure 29: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Home Care, 2017–2028

Figure 30: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Others, 2017–2028

Figure 31: Global Point-of-Care Diagnostics Market Value Share Analysis, by Region, 2020 and 2028

Figure 32: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by Region, 2021–2028

Figure 33: North America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017–2028

Figure 34: North America Point-of-Care Diagnostics Market Value Share Analysis, by Country, 2020 and 2028

Figure 35: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by Country, 2021–2028 

Figure 36: North America Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028

Figure 37: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021–2028

Figure 38: North America Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028

Figure 39: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021–2028

Figure 40: North America Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028

Figure 41: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021–2028

Figure 42: Europe Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017–2028

Figure 43: Europe Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-Region, 2020 and 2028

Figure 44: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

Figure 45: Europe Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028

Figure 46: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021–2028

Figure 47: Europe Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028

Figure 48: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021–2028

Figure 49: Europe Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028

Figure 50: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021–2028

Figure 51: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017–2028

Figure 52: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-region, 2020 and 2028

Figure 53: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

Figure 54: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028

Figure 55: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021–2028

Figure 56: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028

Figure 57: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021–2028

Figure 58: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028

Figure 59: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021–2028

Figure 60: Latin America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017–2028

Figure 61: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-Region, 2020 and 2028

Figure 62: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-Region, 2021-2028

Figure 63: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028

Figure 64: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021–2028

Figure 65: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028

Figure 66: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021–2028

Figure 67: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028

Figure 68: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021–2028

Figure 69: Middle East & Africa Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017–2028

Figure 70: Middle East & Africa Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-Region, 2020 and 2028

Figure 71: Middle East & Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-Region, 2021-2028

Figure 72: Middle East & Africa Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028

Figure 73: Middle East & Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021–2028

Figure 74: Middle East & Africa Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028

Figure 75: Middle East & Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021–2028

Figure 76: Middle East & Africa Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028

Figure 77: Middle East & Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021–2028

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

751

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved